Neurochemical changes during discontinuation of lithium prophylaxis. II. Alterations in platelet serotonin function.
D000328:Adult; D001714:Bipolar Disorder / Q000097:blood / Q000188:drug therapy*; D001792:Blood Platelets / Q000187:drug effects*; D002352:Carrier Proteins; D005260:Female; D006801:Humans; D007700:Kinetics; D008094:Lithium / Q000009:adverse effects* / Q000627:therapeutic use; D016651:Lithium Carbonate; D008297:Male; D011955:Receptors, Drug; D017981:Receptors, Neurotransmitter / Q000187:drug effects; D012701:Serotonin / Q000097:blood*; D013375:Substance Withdrawal Syndrome / Q000097:blood*
D002352:Carrier Proteins; D011955:Receptors, Drug; D017981:Receptors, Neurotransmitter; C027775:imipramine receptor; D016651:Lithium Carbonate; D012701:Serotonin; D008094:Lithium